Elevance Health, Inc.
ELV
Unten findest du den Live-Kurs für Elevance Health, Inc. (ELV), einen 1-Jahres-Chart, 8 Indikatoren (RSI, MACD, Bollinger, MA, EMA, Stochastic, ATR, Volumen) und einen Vergleichsmodus. Hinzufügen zum Portfolio, auf die Beobachtungsliste setzen oder einen Preisalarm einrichten — alles in einem.
Elevance Health, Inc. (ELV) ist ein in United States ansässiges Healthcare-Unternehmen. Tätig in der Branche Healthcare Plans, beschäftigt rund 96,129 Mitarbeiter:innen. Im vergangenen Jahr bewegte sich ELV zwischen 273.71 und 436.24 USD. Das Trailing-KGV liegt bei rund 16.5, die Marktkapitalisierung bei etwa 80.92B USD. Aktuell wirft die Aktie eine Dividendenrendite von 1.84 % ab.
- Prev close
- $372.85
- Volume (24h)
- $716.45M
- Market cap
- $80.92B
- Currency
- USD
Bewertung
52/ 100 · Gemischt
- Wert72
- Qualität35
- Momentum57
- Wachstum24
- Risiko78
- Dividende57
- Liquidität44
Komposit aus öffentlichen Marktdaten. Nur zur Information — keine Anlageberatung.
Trendprojektion
Wohin der jüngste Trend zeigt, wenn er sich fortsetzt.
- +5 Bars
- 375.9831 +0.77%
- +20 Bars
- 379.9838 +1.84%
- +60 Bars
- 381.5429 +2.26%
- +120 Bars
- 381.6002 +2.28%
Lineare Regressions-Fortschreibung — keine Vorhersage, keine Anlageberatung. ±1σ ≈ 68% · ±2σ ≈ 95%: ±0.0405 USD.
Interpretation
Die zusammengesetzten Signale wirken gemischt. Stärke: Risikoprofil mit schwäche: wachstum. Kurs liegt in der Mitte der jüngsten Spanne, Trend zeigt nach oben.
Beschreibende Beobachtung — keine Anlageberatung.
Bewertungs-Aufschlüsselung
Die Rohwerte hinter jedem Pillar — so siehst du, was die zusammengesetzte Bewertung liest.
- Wert72/100
Wert wirkt solide — getragen von KGV (16.5).
KGV:16.5KBV:1.81PEG:1.32 - Qualität35/100
Qualität wirkt schwach — getragen von Bruttomarge (25.99%).
EK-Rendite:11.13%GK-Rendite:3.83%Nettomarge:2.47%Bruttomarge:25.99% - Momentum57/100
Momentum wirkt gemischt — getragen von 52-Wo. Veränderung (34.96%).
52-Wo. Veränderung:34.96% - Wachstum24/100
Wachstum wirkt fragil — getragen von EPS-Wachstum (-13.10%).
Umsatzwachstum:1.40%EPS-Wachstum:-13.10% - Risiko78/100
Risiko wirkt stark — getragen von Verschuldungsgrad (68.95).
Beta:0.68Verschuldungsgrad:68.95Leerverkaufsquote:3.10% - Dividende57/100
Dividende wirkt gemischt — getragen von Ausschüttungsquote (30.34%).
Dividendenrendite:1.84%Ausschüttungsquote:30.34% - Liquidität44/100
Liquidität wirkt schwach — getragen von Liquidität 3. Grades (1.52).
Liquidität 3. Grades:1.52Liquidität 2. Grades:1.37
Abgeleitet aus öffentlichen Marktdaten — informativ, keine Anlageberatung.
Referenzniveaus
Fibonacci-Retracements und -Extensions im jüngsten Bereich.
Nur Referenz — keine Anlageberatung.
Diese Koordinaten beschreiben Preisballungen aus der Vergangenheit, nicht wo gekauft oder verkauft werden sollte. Recherchiere selbst, bevor du handelst.
- ResistanceFib-Extension +161.8%615.5467 USD+64.98% vom aktuellen Kurs
- ResistanceFib-Extension +100%547.06 USD+46.62% vom aktuellen Kurs
- ResistanceFib-Extension +61.8%504.7267 USD+35.28% vom aktuellen Kurs
- ResistanceFib-Extension +27.2%466.383 USD+25.00% vom aktuellen Kurs
- ResistanceFib-Retracement 23.6%410.0865 USD+9.91% vom aktuellen Kurs
- ResistanceFib-Retracement 38.2%393.9068 USD+5.57% vom aktuellen Kurs
- ResistanceFib 50% Mittelpunkt380.83 USD+2.07% vom aktuellen Kurs
- Aktuell373.11 USD
- SupportFib-Retracement 61.8%367.7532 USD-1.44% vom aktuellen Kurs
- SupportFib-Retracement 78.6%349.1355 USD-6.43% vom aktuellen Kurs
- SupportFib-Extension −27.2%295.277 USD-20.86% vom aktuellen Kurs
- SupportFib-Extension −61.8%256.9333 USD-31.14% vom aktuellen Kurs
- SupportFib-Extension −100%214.6 USD-42.48% vom aktuellen Kurs
Financials
- 52w high
- $436.24
- 52w low
- $273.71
- 52w change
- 34.96%
- Day high
- $377.76
- Day low
- $365.38
- P/E (TTM)
- 16.5
- Forward P/E
- 12.58
- PEG
- 1.32
- Price / Book
- 1.81
- Beta (5Y)
- 0.68
- Enterprise value
- 74.59B
- EV / Revenue
- 0.37
- EV / EBITDA
- 8.96
- EPS (TTM)
- $22.61
- Forward EPS
- $29.65
- Dividend yield
- 1.84%
- Dividend rate
- $6.88
- Payout ratio
- 30.34%
- Revenue (TTM)
- 201.11B
- EBITDA
- 8.32B
- Free cash flow
- 4.31B
- Total cash
- 37.51B
- Total debt
- 31.04B
- Debt / Equity
- 68.95
- Current ratio
- 1.52
- Quick ratio
- 1.37
- Profit margin
- 2.47%
- Gross margin
- 25.99%
- Return on assets
- 3.83%
- Return on equity
- 11.13%
- Shares outstanding
- 216.87M
- Float
- 216.41M
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.
Analyst & Risk
- Beta (vs S&P 500)
- 0.68
- less volatile
- 52-week change
- 34.96%
- Short % of float
- 3.10%
- Short ratio (days)
- 3.32
- Debt / Equity
- 68.95
- very high leverage
- Current ratio
- 1.52
- Quick ratio
- 1.37
- ROE
- 11.13%
- ROA
- 3.83%
- PEG ratio
- 1.32
- fair
- EV / Revenue
- 0.37
- EV / EBITDA
- 8.96
- Revenue growth
- 1.40%
- Earnings growth
- -13.10%
- EBITDA
- 8.32B
- Free cash flow
- 4.31B
- Total cash
- 37.51B
- Total debt
- 31.04B
- Insider holdings
- 0.18%
- Institutional
- 93.54%
Recent rating changes
- 2026-07-17Leerink PartnersMarket Perform → Market Performmain
- 2026-07-16RBC CapitalSector Perform → Sector Performmain
- 2026-07-16Wells FargoOverweight → Overweightmain
- 2026-07-16GuggenheimBuy → Buymain
- 2026-07-16BarclaysOverweight → Overweightmain
- 2026-07-16BairdNeutral → Neutralmain
- 2026-07-14TD CowenBuy → Buymain
- 2026-07-14Truist SecuritiesBuy → Buymain
Financial documents
- Periodic Financial Reports10-Q2026-07-15
- Annual report of employee stock purchase11-K2026-06-17
- Corporate Changes & Voting Matters8-K2026-06-10
- Corporate Changes & Voting Matters8-K2026-05-13
- Corporate Changes & Voting Matters8-K2026-04-22
- Proxy StatementsDEFA14A2026-03-27
- Corporate Changes & Voting Matters8-K2026-03-10
- Corporate Changes & Voting Matters8-K2026-03-02
- Corporate Changes & Voting Matters8-K2026-02-26
- Periodic Financial Reports10-K2026-02-06
- Corporate Changes & Voting Matters8-K2026-01-28
- Corporate Changes & Voting Matters8-K2025-12-10
Aktuelle Nachrichten
- Equal-Weight Strategy RSP Could Outrun SPY if This Macro Shift Continues24/7 Wall St.1d ago
- Podiatrist-approved sneakers and shoes help you put your best foot forward — from $25TheStreet1d ago
- Elevance Health CEO Boudreaux Buys $1 Million in Shares. What Does This Mean For its 2026 Outlook?Motley Fool2d ago
- Leerink Partners Adjusts PT on Elevance Health to $395 From $364, Maintains Market Perform RatingMT Newswires2d ago
- Bernstein Adjusts Price Target on Elevance Health to $488 From $482, Maintains Outperform RatingMT Newswires2d ago
- What's A Strong Quarter Worth When Elevance Health Is Ditching Its Own Markets?Trefis2d ago
- Elevance Health CEO Snaps Up Stock After Post-Earnings SlideBarrons.com2d ago
- Elevance Health Insider Bought Shares Worth $1,002,230, According to a Recent SEC FilingMT Newswires2d ago
Verwandt
Weitere Assets in dieser Kategorie.
- 8306.TMitsubishi UFJ Financial Group, Inc.3,473 USD-4.30%
- 7203.TToyota Motor Corporation2,899.5 USD-0.33%
- 9984.TSoftBank Group Corp.5,424 USD-9.01%
- 6758.TSony Group Corporation3,470 USD+0.93%
- 6861.TKeyence Corporation70,880 USD-4.28%
- NVDANVIDIA Corporation202.81 USD-2.21%
- AAPLApple Inc.333.74 USD+0.14%
- 0700.HKTencent Holdings Limited477.8 USD+3.51%
Live-Diskussion
Anmelden to join the discussion.
- Noch keine Kommentare. Sei der Erste.